MX2012003290A - Composicion para reducir el nivel de acido urico en la sangre. - Google Patents

Composicion para reducir el nivel de acido urico en la sangre.

Info

Publication number
MX2012003290A
MX2012003290A MX2012003290A MX2012003290A MX2012003290A MX 2012003290 A MX2012003290 A MX 2012003290A MX 2012003290 A MX2012003290 A MX 2012003290A MX 2012003290 A MX2012003290 A MX 2012003290A MX 2012003290 A MX2012003290 A MX 2012003290A
Authority
MX
Mexico
Prior art keywords
composition
uric acid
acid level
blood uric
lowering blood
Prior art date
Application number
MX2012003290A
Other languages
English (en)
Inventor
Fuminori Kimura
Hideaki Kitajima
Takao Tanaka
Toru Nishikawa
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of MX2012003290A publication Critical patent/MX2012003290A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Abstract

Una composición para reducir un nivel de ácido úrico en la sangre se caracteriza porque comprende taurina como un ingrediente activo.
MX2012003290A 2009-09-17 2010-09-10 Composicion para reducir el nivel de acido urico en la sangre. MX2012003290A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009215092 2009-09-17
PCT/JP2010/065627 WO2011034006A1 (ja) 2009-09-17 2010-09-10 血液中の尿酸値を低下させるための組成物

Publications (1)

Publication Number Publication Date
MX2012003290A true MX2012003290A (es) 2012-04-30

Family

ID=43758611

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012003290A MX2012003290A (es) 2009-09-17 2010-09-10 Composicion para reducir el nivel de acido urico en la sangre.

Country Status (9)

Country Link
US (1) US9101588B2 (es)
JP (1) JP6112767B2 (es)
KR (1) KR20120068006A (es)
CN (1) CN102655862A (es)
IN (1) IN2012DN01863A (es)
MX (1) MX2012003290A (es)
SG (1) SG10201405790UA (es)
TW (1) TW201116275A (es)
WO (1) WO2011034006A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2013018706A1 (ja) * 2011-08-03 2015-03-05 大正製薬株式会社 Ｕｒａｔ１活性を調節するための組成物
JP7262090B2 (ja) 2017-10-06 2023-04-21 ザインエレクトロニクス株式会社 合成抵抗回路および可変利得増幅回路

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006213607A (ja) * 2005-02-01 2006-08-17 Asahi Breweries Ltd 尿酸値低下剤

Also Published As

Publication number Publication date
US20120190886A1 (en) 2012-07-26
IN2012DN01863A (es) 2015-07-17
CN102655862A (zh) 2012-09-05
US9101588B2 (en) 2015-08-11
KR20120068006A (ko) 2012-06-26
SG10201405790UA (en) 2014-11-27
TW201116275A (en) 2011-05-16
JP6112767B2 (ja) 2017-04-12
WO2011034006A1 (ja) 2011-03-24
JPWO2011034006A1 (ja) 2013-02-14

Similar Documents

Publication Publication Date Title
UA104203C2 (en) Microbiocidal heterocycles
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
WO2009041705A3 (en) 5-membered heterocyclic compounds as proton pump inhibitors
EP2432774A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR MODULATING URIC ACID RATES
MY158982A (en) Heterocyclic compound
WO2011073279A3 (fr) Procédé de traitement cosmétique impliquant un composé apte à condenser in situ
MY183312A (en) Pharmaceutical formulation
WO2008113559A3 (en) Indolizines and aza-analog derivatives thereof as cns active compounds
MX2012006233A (es) Nuevos compuestos de espiropiperidina.
WO2010128050A3 (en) Dihydroorotate - dehydrogenasee inhibitors as virostatic compounds
MX2012008141A (es) Compuestos y metodos.
WO2009156724A3 (en) Pyrido-indole-carboxylic acid compounds
WO2010119102A3 (de) Pharmaceutische zusammensetzung enthaltend protonenpumpenhemmer zur behandlung von dermatologischen autoimmunerkrankungen
MX2014005399A (es) Metodos para tratar gota en sub-poblaciones de pacientes.
HRP20130668T1 (en) Kit for collecting blood, preferably peripheral blood, for the production of stem cells
UA103197C2 (uk) Застосування ніфуртимоксу для лікування хвороб, спричинених трихомонадами
MX2012003290A (es) Composicion para reducir el nivel de acido urico en la sangre.
HK1154032A1 (en) A process for the ultrapurification of alginates
MX2012004087A (es) Sulfonamidas para la prevencion de diabetes.
IN2012DN01223A (es)
EP2471542A4 (en) THERAPEUTIC AGENT FOR HEPATIC DISEASES
MX2011011180A (es) Compuestos que tienen efecto fisiologico.
WO2010128755A3 (ko) 트레오네이트를 유효성분으로 하는 탈모 예방 또는 치료용 조성물
WO2011161295A3 (es) Uso de compuestos anticalcineurina para el tratamiento de patologías que cursan con neovascularización ocular
UA38601U (en) 2,2'-dithioxo-4,4'-dioxo-[5,5']-bithiazolidinyl-idene-diyl-3,3'-dibutanoic acid diarylamides having antitumor activity

Legal Events

Date Code Title Description
FA Abandonment or withdrawal